What is the Breast Ultrasound Market Size?
The global breast ultrasound market size was estimated at USD 2.99 billion in 2026 and is projected to reach approximately USD 9.66 billion by 2035, representing a CAGR of 13.94% from 2026 to 2035. The rising prevalence of breast cancer is the key factor driving market growth. The increase in demand for breast ultrasound, along with technological advancements, can fuel market growth further.
Breast Ultrasound Market Key Takeaways
- The global breast ultrasound market was valued at USD 2.99 billion in 2026.
- It is projected to reach USD 9.66 billion by 2035.
- The breast ultrasound market is expected to grow at a CAGR of 13.94% from 2026 to 2035.
- North America dominated the breast ultrasound market with the largest market share of 36% in 2026.
- Asia Pacific region is expected to expand at the fastest CAGR of 15.41% over the forecast period.
- By product, the automated breast ultrasound (ABUS) segment contributed the highest market share of 65% in 2026.
- By product, the conventional breast ultrasound (CBUS) segment is anticipated to grow at the fastest rate during the forecast period.
- By end use, the hospitals segment accounted for the largest market share of 49% in 2026.
- By end use, the diagnostics imaging laboratories segment is anticipated to grow at a notable CAGR of 14.51% over the projected period.
Market Overview
Breast ultrasound is a non-invasive diagnostic technique that utilizes high-frequency sound waves to create images of the breast tissue. The market includes products like probes, ultrasound systems, and other accessories. Government initiatives coupled with the help of some NGOs to increase awareness about breast health are also an important element of women's healthcare. As the need for early detection increases, the breast ultrasound market can play a crucial role in enhancing breast cancer outcomes.
Role of Artificial Intelligence in Breast Ultrasound
Artificial Intelligence (AI) is gaining popularity in the detection of various images. Hence, it has been widely used in the ultrasound of the breast to do a quantitative assessment, which helps maintain the diagnosis's precision. AI-assisted breast ultrasound tools may support lesion characterization and image interpretation, but performance depends on clinical validation and the specific system used. Upgrading and standardizing workflow, identifying issues, and reducing monotonous tasks can transform the breast ultrasound market.
Breast Ultrasound Market Growth Factors
- Growing awareness of breast cancer risk and the importance of timely diagnostic evaluation may support demand for breast imaging services, including breast ultrasound.
- Product innovation, distribution expansion, and investment by established imaging-equipment manufacturers may support the adoption of breast ultrasound systems.
- Technological advances introduced by imaging-equipment manufacturers and research organizations may support broader adoption of breast ultrasound systems.
Market Dynamics
Driver
Integration of telemedicine
The integration of breast ultrasound systems with telemedicine platforms, especially for remote consultations, is an emerging breast ultrasound market trend. By conducting remote consultations between healthcare professionals and patients, BUS can optimize expert interpretations and timely screenings. Additionally, this approach provides the ability for more sophisticated utilization of healthcare resources and decreased patient wait times.
Restraint
Economic challenges faced by breast imaging centers
Sometimes, breast imaging centers confront major economic challenges in the form of reduced reimbursement, rising patient demand, and stringent federal regulations. However, the density of the breast can be a significant diagnostic challenge, decreasing the sensitivity of ultrasound techniques. Dense breast tissue can make it challenging to interpret mammograms, leading to missed cancer diagnoses.
Opportunity
Increasing preference for non-ionizing diagnostic techniques
An emerging trend in the global breast ultrasound market is the rising preference for non-ionizing imaging techniques because of increasing health concerns related to radiation exposure. Breast ultrasound offers a non-ionizing imaging option that can complement mammography in selected patients, including some women with dense breast tissue. Its use depends on clinical indications and applicable screening guidelines. Furthermore, this inclination towards non-ionizing diagnostic techniques is anticipated to fuel the growth of the market.
Segment Insights
Product Insights
The automated breast ultrasound (ABUS) segment led the breast ultrasound market in 2026. The dominance of the segment can be attributed to the ongoing technological advancements, user-friendly features offered by this device, and regulatory approvals. Additionally, ABUS provides automated whole-breast imaging and may be used as a supplemental imaging option in selected patients, including some women with dense breast tissue. Healthcare settings are also adopting automated whole-breast ultrasound systems due to their efficient features and performance.
The conventional breast ultrasound (CBUS) segment is anticipated to grow at the fastest rate in the breast ultrasound market during the forecast period. The growth of the segment can be linked to the increasing adoption of CBUS from various organizations as it detects breast abnormalities more effectively. However, many diagnostic centers and hospitals still use conventional breast ultrasound because of numerous other reasons. Which can impact positively the segment growth in the market.
End Use Insights
The hospitals segment dominated the breast ultrasound market by holding the largest market share. The dominance of the segment can be credited to the increasing adoption of advanced diagnostic tools by hospitals, like automated whole-breast ultrasound systems, to improve the precision of breast health diagnoses. The integration of this innovative system within hospitals is important for the management and early detection of breast conditions, which makes them essential in healthcare scenarios.
The diagnostics imaging laboratories segment is anticipated to grow at the fastest rate in the breast ultrasound market over the projected period. The growth of the segment is linked to the rising number of diagnostic centers across the globe, the high incidence of breast cancer disease, and the increasing need for imaging techniques. In addition, diagnostic imaging centers offer specialized diagnostic services coupled with innovative imaging technologies, resolving the demand for standardized diagnostic services beyond conventional hospital environments.
Regional Insights
North America's Breast Ultrasound Market Leadership Driven by Early Detection and Favorable Reimbursement Policies
North America dominated the breast ultrasound market in 2026. The dominance of the segment can be attributed to the strong presence of developed infrastructure in the healthcare industry, along with the increasing cases of breast cancer in the region. Furthermore, the presence of major market players, along with significant investments in R&D, will propel the market growth soon. Also, favorable reimbursement initiatives aimed at optimizing the early identification of breast cancer have facilitated the widespread acceptance of the breast ultrasound market in the region.
What is the U.S. Breast Ultrasound Market Size?
The U.S. breast ultrasound market size was exhibited at USD 840 million in 2026 and is predicted to reach around USD 2,770 million by 2035, growing at a CAGR of 14.11% from 2026 to 2035.
U.S. Market Trends
ABUS is used in selected U.S. clinical settings as a supplemental imaging option, including for some women with dense breast tissue. The use of AI makes the workflow more efficient and lesion detection possible. Another trend is the move towards risk-based screening methods, which are more individualized, enhance early detection, and patient-specific diagnostic measures.
Asia Pacific Breast Ultrasound Growth Fueled by Early Detection Awareness and Advanced Imaging Technologies
Asia Pacific is expected to grow at the fastest rate over the forecast period. The growth of the region can be driven by increasing awareness about breast cancer and its treatment in the region. However, nations like China, Japan, and South Korea are adopting the ABUS more rapidly. These countries have an increasing number of breast cancer cases due to a substantial population rise driving the breast ultrasound market growth in the region.
China Market Trends
The market in China is fuelled by massive government screening programs aimed at covering a large population base. Dense breast tissue is of high prevalence, making ultrasound a major tool to rely on. The market is moving to more sophisticated digital, 3D, and AI-powered systems, enhancing the accuracy of the diagnosis and increasing the potential of healthcare.
What Are the Driving Factors of The Breast Ultrasound Market in Europe?
Europe is expected to grow at a significant CAGR during the forecast period. The UK, France, and Germany are at the forefront. AI-assisted imaging and contrast-enhanced ultrasound are areas of clinical development and evaluation. Add a specific European Society of Radiology guideline or statement before attributing an endorsement to the organization.
Germany Market Trends
Ultrasound became a mandatory additional imaging device used in screening programs in Germany. Advanced handheld and automated devices are in high demand because of high-quality requirements. The innovation and high-performance ultrasound systems utilization are further encouraged by technological development and the decentralization of diagnostic centers.
How is the Middle East & Africa Performing in The Breast Ultrasound Market?
The Middle East & Africa are expected to grow at a notable CAGR during the forecast period. A strategic modernization of healthcare is contributing to the development of the MEA region. The implementation of AI-based diagnostic tools like Lunit INSIGHT is enhancing the ability to detect diseases at an earlier stage. Some nations, such as Qatar and Saudi Arabia, are upgrading cancer care facilities, especially those in government health facilities, to increase the effectiveness and access to cancer diagnosis.
South Africa Market Trends
South Africa is also investing in private healthcare facilities and advanced imaging facilities, which increases the demand for new ultrasound systems. The focus on early detection in younger and symptomatic patients is increasing. Mobile screening services can boost the availability of breast imaging services in rural and underserved areas by expanding mobile screening units.
Breast Ultrasound Market Companies
- GE HealthCare.
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- CANON MEDICAL SYSTEMS CORPORATION
- Telemed Medical Systems Srl
- Hologic, Inc.
- FUKUDA DENSHI
- Supersonic Imagine
- Lunit Inc.
- Delphinus Medical Technologies, Inc.
Recent Developments
- In April 2026, QT Imaging Holdings launched the QTI Imaging-Olea Viewer, a radiation-free breast health imaging technology developed with Olea Medical, known for advanced imaging software solutions. (Source: https://www.citybiz.co)
- In January 2026, iSono Health launched ATUSA, an FDA-cleared, wearable 3D breast ultrasound platform, enhancing imaging accessibility in clinics. ATUSA captures full 3D volumes in approximately two minutes per breast, roughly 10x faster than manual handheld ultrasound. (Source: https://www.itnonline.com)
Breast Ultrasound Market Segments
By Product
- Conventional Breast Ultrasound (CBUS)
- Automated Breast Ultrasound (ABUS)
By End Use
- Hospital
- Diagnostics Imaging Laboratories
- Others
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Tags
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Table Of Content
Get a Sample
sales@precedenceresearch.com
Schedule a Meeting